HSV-1

HSV-1 news focuses on antiviral breakthroughs, such as FDA's approval of Hovilpri for drug-resistant herpes in immunocompromised adults, underscoring treatment advances.

FDA Approves Hovilpri for Herpes Lesions Resistant to Antiviral Treatment in Immunocompromised Adults

Published on 10/10/2026